Hospital & Unit Operations
T

TransformativeMed

TransformativeMed, based in Seattle under chief executive David Stone, sells the CORES platform: clinician facing workspaces embedded inside the Oracle Health record, now positioned as what the company calls an agentic clinical operating system. The platform page names the integration precisely, SMART, FHIR and MPages embedded in PowerChart, with read and write access across orders, documentation, reference data and workflows.

The long standing product is more than fifty prebuilt workflow modules that reorganise record data for each acute care team: specialty patient lists, rounding preparation and handoff, discharge planning, task management, alert routing through Core Notify, secure messaging and a mobile companion that reads from and writes back to the record. The company describes building them through knowledge engineering and configuration rather than learning. Core Diabetes adds inpatient glycemic management: a patient flowsheet, a unit dashboard, decision support for ordering intravenous and subcutaneous insulin, nurse titration tools, an Advisor offering automated treatment recommendations, and GlucoCare, an intravenous insulin dosing calculator from Pronia Medical Systems that the FDA cleared in 2008. That clearance covers the partner's intravenous calculator; no regulatory position is stated for the subcutaneous dosing support or the Advisor.

The newer layer is agentic. Multi agent orchestration is stated to be powered by Vantiq, and a semantic AI data platform prepares clinical notes for large language models. Its lead application is Core Discharge, introduced in 2026: agents read documentation continuously, extract discharge tasks, equipment needs, barriers and readiness into the plan, keep an estimated discharge date current, and question the rehab, primary team, disposition and consult services through the mobile app. It is sold on discharge before noon, bed capacity and throughput. No language model provider, oversight boundary, accuracy figure, business associate position or security attestation is published.

Deployments described in customer announcements include University of Tennessee Medical Center since 2013, University of Washington Medicine, University of Alabama at Birmingham, a Veterans Affairs division and King Faisal Specialist Hospital, and the company was named Best in KLAS for clinician digital workflow in 2026.

AI Health Index verifiedSeptember 22, 2026
Compare TransformativeMed with other vendors
Founded
—
Headquarters
Seattle, Washington, United States
Categories
hospital-operations, clinical-decision-support
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
CC on AI CentralityArtificial intelligence is a feature layer on a product whose value stands without it. A learned component is a model whose parameters are estimated from data: machine learning, or a statistical model fitted to population data, including one then updated on the patient measurements. A fixed formula, a rule set, or a feedback controller that adjusts a dosing factor from the patient own readings is not one, however patient specific its output and whatever the vendor calls the adjustment.
Vendor Published

A learned component is now in the product, sitting on top of a workflow platform that works without it. The CORES platform page describes two model driven layers: a semantic AI data platform that extends the record's data model for large language models and turns free text clinical notes into structured items such as expected discharge dates, durable medical equipment needs, consult statuses and care plans; and multi agent orchestration, supplied by Vantiq, in which agents perceive live record signals, apply clinical logic and launch coordinated actions across care teams. Language models reading notes are a learned component, and the orchestration comes from a partner.

The value underneath stands without them. The company's long standing asset is more than fifty prebuilt workflow modules embedded in the record: specialty patient lists, rounding and handoff views, task management, alert routing through Core Notify, secure messaging, a mobile companion and a diabetes module, built through what the company describes as knowledge engineering and configuration. A hospital would still hold those workspaces with every model removed, and the platform page itself describes hybrid workflows that combine proven applications with agents.

DD on Autonomy and Oversight ModelNo oversight structure is published. An absolute claim that the system does not err grades here too, because a buyer who believes it will not build the review step that would catch a failure.
Vendor Published

Autonomy is claimed in strong terms and no oversight structure is published. The platform page describes an agentic clinical operating system in which multiple AI agents perceive, reason, plan and autonomously execute multi step clinical and administrative workflows, contrasting it with passive tools that only make suggestions; agents launch coordinated actions across care teams; and the integration reads and writes across orders, documentation, reference data and workflows inside the record.

The discharge product states it outright. Core Discharge describes autonomous chart review in which agents extract discharge tasks, equipment requirements, barriers and readiness indicators from documentation as it is written, and says no manual review is required; service agents then question the rehab, primary team, disposition and consult services by mobile and update the plan themselves. The team dashboard shows AI summaries with their source documentation on hover, which lets a reader check a summary they choose to open. A statement that review is unnecessary tells a buyer not to build the step that would catch a wrong estimated discharge date or a missed equipment need.

Nothing published says what the agents may not do, which actions need a clinician's approval before they take effect, what happens when an agent is unsure, or how a clinician sees and reverses an action an agent took. The only nod to people is that workflows are hybrid, combining the existing applications with agents, which describes the product mix rather than a control.

The older product was a different proposition: workspaces that assemble record data and route tasks and alerts, with clinicians doing the rest. That description no longer covers what is sold.

BB on Model and Technology TransparencyThe approach or the suppliers are named without the version and update discipline behind them. Naming a supplier is the entry to this band both here and on Model Supply Chain Disclosure, which ask different questions of the same disclosure: who receives the data, and what produces the output.
Vendor Published

The architecture is named layer by layer and one supplier is identified; the version discipline is not. The platform page describes four layers: multi agent orchestration, stated to be powered by Vantiq, in which agents read live record signals and launch actions; a semantic AI data platform that extends the record data model for large language models and extracts structured items from clinical notes; more than fifty prebuilt workflow modules; and an MCP based interface layer for agent integration. The record integration is named precisely: SMART, FHIR and MPages, embedded in PowerChart. Naming the orchestration supplier shows where part of the intelligence comes from.

What is missing is the model layer and its change practice. No language model or provider is named, the page describes the platform as built to adopt quickly evolving language models without saying which it uses now or how a change is tested, and no accuracy figure is published for the note extraction, which drives discharge dates and equipment needs.

The older half of the product remains inspectable in a way learned systems are not: specialty workspaces built as configuration on the record's own extension toolkit can be read by the institution running them.

CC on Model Supply Chain DisclosureThe architecture is described and no model provider is named. Naming a hosting provider alone does not lift a record out of this band. Record the host in the note, because it matters for residency and breach scope, and grade on the model layer, which is the question this axis is named for.
Vendor Published

One party in the chain is named, Vantiq, and the model layer is not. The platform page states that multi agent orchestration is powered by Vantiq, so a buyer knows that a separate company's real time platform receives live record signals and runs the agents. It also describes a semantic AI data platform that prepares clinical notes for large language models, without naming which model or provider sits behind it, and says the platform is built to adopt quickly evolving models.

The embedded workspaces keep a short chain for the older product, since they run inside the customer's record through its own extension framework. The newer chain is the one that matters and it is undescribed: nothing says what Vantiq receives or retains, where note text is sent for the language model, whether any model provider sees identifiable notes, or whether those parties are bound by the same terms as the company. No subprocessor list exists, and the only privacy document on the site covers website visitors.

CC on Clinical and Operational EvidenceNamed customers, or vendor reported percentages with no method, denominator or reference standard. Scale of use is recorded here and is not treated as evidence of benefit.
Vendor Published

Long lived deployments, customer quotes with figures, and no measured outcome with a method behind it. The company has been named Best in KLAS for clinician digital workflow in 2026, and deployments described in customer announcements run for years at academic medical centers: University of Tennessee Medical Center since 2013, University of Washington Medicine including Harborview, University of Alabama at Birmingham, a Veterans Affairs division and King Faisal Specialist Hospital. KLAS measures customer satisfaction and product experience, not outcomes.

The figures published are customer quotes. On the Core Diabetes page an unnamed manager reports insulin errors down 20 percent and nurse error risk down 33 percent, and time to treatment for out of range glucose down 73 percent at one facility and 28 percent at another; a regional director is quoted on observation time falling from 26 to 24 hours; and a figure of up to 45 minutes saved per provider per day has been claimed. None names the site, period, method or denominator.

The newest product has no evidence of its own. Core Discharge cites one result, UW Medicine's discharge before noon rate rising from 12 to 17 percent in 2018. That predates the agentic module, which the page presents as amplifying those gains and which was announced in August 2026 with University of Tennessee Medical Center as a solution the two are building together. Nothing published measures the agents.

No peer reviewed publication or independent evaluation appears.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

The data path is sketched and nothing is committed about it. The platform page describes the workspaces as embedded in PowerChart through SMART, FHIR and MPages, which keeps much of the handling where the record already lives, and then adds two layers that change the path: a semantic AI data platform that extends the record data model for large language models and reads clinical notes, and agent orchestration supplied by Vantiq, a separate company's platform. A mobile companion also reads and writes patient data on clinicians' devices.

No retention statement, de identification position, training position or safeguard description is published for any of it. The privacy statement and terms on the site cover website visitors only, so there is no document a buyer can read about patient data at all.

The language model layer is the open question. Clinical notes are the richest and most identifying text in the record, and the page says they are transformed for language models without saying where that processing happens, whether notes leave the customer's environment, what the partner platform retains, or whether any of it trains a model. Nor is it said what the mobile application caches on a device.

Regulatory and Compliance
DD on HIPAA and BAA PostureNo statement of status and no privacy document that reaches the product. Both halves are absent at this grade: a service level privacy document on its own lifts a vendor to the band above even where no status is stated. A website privacy notice, including one that says it does not cover customer data, does not reach the product, so a vendor whose only document is that notice and who states no status grades here.
Vendor Published

No statement of status and no privacy document that reaches the product. The footer links a privacy statement and terms of use, and both say in their opening lines that they govern the company's website: personal information from website users, newsletter and marketing contacts, and Google Analytics. Neither mentions protected health information, patients or business associate status, and no agreement, template or tier is published.

Given deployments inside large academic health systems and a Veterans Affairs division, agreements almost certainly exist in private; none is readable before contracting.

The product's current shape makes the missing instrument more consequential than it was. The platform now describes agents with read and write access to orders and documentation, a language model layer processing clinical notes, an external orchestration partner, and a mobile companion that reads and writes patient data on clinicians' devices. Each of those is a place a business associate agreement and its subcontractor terms would need to reach.

DD on Security Certifications and Trust CenterControls are asserted with nothing independent behind them, or nothing is published. Read the note before concluding anything: this is the grade most often corrected on a second pass, because assurance material frequently sits on a parent domain or inside an old announcement rather than on the product pages.
Vendor Published

Nothing independent is published. The footer's privacy statement and terms cover the website, and no page names a SOC 2 report, HITRUST certification, ISO 27001, trust center, penetration testing statement or vulnerability disclosure policy.

One detail suggests more exists than is shown. The platform runs at a Veterans Affairs division, and federal deployment normally requires a product to clear a formal security authorization; no such assessment is mentioned anywhere on the site.

The product's current architecture raises the stakes. Agents with write access to orders and documentation, an external orchestration platform, a language model layer over clinical notes and a mobile companion carrying patient data are four surfaces a security review would want to scope, and nothing describes how any of them is controlled or tested.

DD on FDA and Regulatory StatusThe positioning is unclear or unsupported: clinical claims with no regulatory position stated, or language implying a status the databases do not carry. An open enforcement action that names the product also grades here, whatever the positioning: an FDA warning letter with no close out letter posted, or a consent decree in force. The note says which of the two applies, and the grade returns to the positioning bands when FDA closes the action.
Vendor Published

Core Diabetes recommends insulin treatment to the ordering provider, and no regulatory position is stated for most of it.

The product page describes decision support for ordering subcutaneous insulin, decision support for nurses giving it, and an Advisor offering "automated treatment recommendations based on analysis of chart information". These ask a provider to start or change a treatment. No position is stated for them: no intended use, nothing on how they are regulated, and nothing showing the protocol rule behind a recommendation at the point of ordering. Chart data shown alongside is the input to a recommendation, not the reasoning that produced the dose.

The solutions page says Core Diabetes includes an FDA cleared algorithm. That clearance belongs to a partner: Pronia Medical Systems' GlucoCare, 510(k) K081388, cleared in August 2008 for calculating intravenous insulin doses to a protocol target range in hospitalized adults, excluding diabetic ketoacidosis. It does not reach the subcutaneous dosing or the Advisor, and the page does not say what it covers. The clearance names no version; the federal device identifier database lists GlucoCare 2.X. The home page names a 140B protocol for nurse IV titration, which Pronia describes as newer than the target ranges it has described as cleared.

The rest of the platform is operational: workspaces, task routing and discharge agents that forecast dates and extract equipment needs. The agents' write access to orders is the second regulatory question.

DD on AI Governance and Bias DisclosureNothing published on how model behavior is governed or tested. Multilingual operation with no subgroup performance sits here when the vendor markets recognition quality as a strength, because a caller the system failed to understand leaves no complaint and no record.
Vendor Published

Nothing published on how the platform's judgments are governed or tested, and there are now two kinds of judgment to govern.

The older kind is editorial. Specialty workflow configuration decides what appears at the top of a nephrologist's patient list, which values surface on rounds and what counts as discharge readiness, and those clinical judgments are encoded by the vendor's knowledge engineers for every institution running the product. They age as practice, formularies and quality measures change, and a view that quietly stopped reflecting current practice keeps rendering with institutional authority. No versioning policy or review cadence for that content is published.

The newer kind is learned. A language model layer extracts discharge dates, equipment needs and care plan items from clinical notes, and agents apply clinical logic and act. Note writing varies by specialty, author and institution, so extraction quality will vary with it, and a missed equipment need or a wrong discharge date falls unevenly on the patients whose notes the model reads least well. No evaluation, monitoring, drift detection or performance by specialty or patient group is published, and the platform is described as ready to swap in newer language models without saying how a swap is tested.

DD on AI Liability and RecourseNothing published on what happens when the system is wrong.
Vendor Published

Nothing published says what happens when the system is wrong, and the product now acts rather than displays. The platform page describes agents that autonomously execute multi step clinical and administrative workflows, with read and write access to orders, documentation and reference data, and a language model layer that turns clinical notes into expected discharge dates, equipment needs and care plan items. A wrong extracted discharge date moves a discharge; a missed equipment need delays one; an action written into an order by an agent becomes part of the record.

No accuracy figure, evaluation method, warranty, service level, indemnity or remediation commitment is published for any of it, and no correction route is described: nothing says how a clinician sees what an agent did, how an agent's action is reversed, or who answers for a harm traced to one. The only legal documents on the site are website terms, which provide the site's materials as is and disclaim reliance on them; no customer agreement is published.

The older workspaces were inspectable configuration controlled by the institution, which put authorship where clinical accountability sits. That property does not carry over to agents and a language model layer, and the published material does not say how it is replaced.

Integration and Deployment
AA on EHR and Interoperability DepthNamed bidirectional integrations with major record systems, verifiable in marketplace listings or integration documentation, with evidence the connection runs in production.
Vendor Published

Depth of record system integration is not a feature of this product; it is the product. The platform page names the mechanism precisely: SMART, FHIR and MPages integration, embedded in Oracle Health's PowerChart, with bidirectional read and write across orders, documentation, reference data and workflows. The workspaces run inside the record rather than beside it, so clinicians do not change application, sign in twice or reconcile two views of the same patient, which is the failure that kills most overlay products. A mobile companion reads from and writes back to the record, and task synchronization, alert routing and secure messaging run across the care team inside the same environment. An MCP based interface layer is described for agent integration.

Production evidence is long and specific: deployments described in customer announcements at University of Tennessee Medical Center since 2013, University of Washington Medicine, University of Alabama at Birmingham, a Veterans Affairs division and King Faisal Specialist Hospital, and a Best in KLAS recognition in 2026 for clinician digital workflow.

The limit is breadth of record systems: the company positions the product around Oracle Health, and nothing describes what is available on another record system.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

Where the workspaces run is clear from the architecture; where the newer layers run is not stated at all, and nothing is committed about either. The platform page says the product is embedded in PowerChart through SMART, FHIR and MPages, which means the specialty workspaces largely extend software the hospital already hosts and data handling stays in the customer's record instance. That follows from the design rather than from any residency commitment, and no hosting provider, region or residency statement is published.

Two layers now sit outside that environment by description: agent orchestration supplied by Vantiq, a separate platform, and a semantic AI data platform that prepares clinical notes for large language models. Nothing says where either runs, in which region, what they store, or how one customer's data is separated from another's. The mobile companion moves patient data onto devices as well.

So a buyer evaluating the product today is evaluating two deployment models under one name: an embedded one that is favorable, and an agentic one that is undescribed. No availability commitment is published for workflows clinicians now depend on.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Vendor Published

The product menu is laid out in full and carries no prices. It lists the workflow products (Core Work Manager, Core Discharge, Core Mobile and Core Notify), a disease product (Core Diabetes) and the CORES platform underneath, which the platform page describes as more than fifty prebuilt workflow modules plus agentic automation and an interface layer. The positioning is explicitly around getting more value from an existing Oracle Health investment at a fraction of the cost, and the route in is a demo request.

What no page answers is the unit of charge, and on an embedded clinical workflow product the candidates diverge: per bed, per facility, per clinician user, per module, or a platform fee, with the agentic layer possibly priced separately because it rests on a partner's platform. Nothing states implementation fees, which for configuration inside a hospital's record are usually substantial, or the term.

BB on Setting and Specialty CoverageCoverage is named with validation behind part of it.
Vendor Published

Specialty breadth inside acute inpatient care is the product thesis. The premise is that one record system cannot suit every acute care team, so the platform ships more than fifty prebuilt workflow modules for specialties and care team roles: specialty patient lists, rounding preparation and handoff, discharge planning, task management, alert routing and secure messaging, with a diabetes module layered on and a mobile companion for work away from a workstation. The agentic layer is described across clinical and administrative workflows, with discharge planning the named use case.

The setting is inpatient acute care across physicians, nursing and multidisciplinary teams on Oracle Health, with deployments described at academic medical centers in the United States, a Veterans Affairs division and a large academic hospital abroad, and a 2026 KLAS recognition for clinician digital workflow. That is validation behind the core.

Coverage is deep within acute inpatient care and absent outside it, with no ambulatory, post acute or community presence, and the agentic workflows are new and carry no named deployment.

Alternatives

Alternatives to TransformativeMed

Vendors in the same categories as TransformativeMed whose graded profiles look most alike, with a line on what each product does.

Similar is not the same, so check that each one does the job you need. No vendor pays for placement.

LiveData, based in Cambridge, Massachusetts, sells perioperative workflow and surgical capacity software to hospitals and ambulatory surgery centers.

HealthCare Logic, based on the Gold Coast in Queensland with offices in Dublin and London, sells SystemView, a hospital performance and patient flow analytics platform.

GE HealthCare Command Center is hospital operations software that pulls streaming data from a hospital's record and resource systems into tiles, small applications that each cover one part…

nextOR GmbH, based in Büren with an office in Berlin, sells nextOR Planning, a self learning program for operating room and multi resource planning in German speaking hospitals.

Copient Health, based in Atlanta, sells ARDEN, software for the perioperative leaders who manage operating room block time at hospitals and ambulatory surgery centers.

Opmed sells an AI platform for hospital operations and scheduling, built first for the operating room.

Ordered by how closely the graded profiles match across the fifteen axes, inside the same categories. See how each axis is graded in the methodology.

Comparisons

Compared With

Each comparison carries a written verdict, the buyer conditions that favor each vendor, and a graded side by side. Pairs that cross a category boundary are grouped separately, and their verdicts state where the boundary sits rather than manufacturing a head to head.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
No pricing published; demo request
Enterprise quote across named workflow products and the CORES platform, sold to Oracle Health hospitals. No unit of charge, rate or term published. Not published. The privacy statement and terms of use cover website visitors only; no business associate status or agreement is stated. Not published. Deployment is configuration inside the customer's Oracle Health record through SMART, FHIR and MPages, which implies implementation work that is nowhere priced. Vendor Published

No price, rate or unit of charge is published. The product menu enumerates the offer: Core Work Manager, Core Discharge, Core Mobile, Core Notify and Core Diabetes, on the CORES platform of more than fifty prebuilt workflow modules with an agentic layer supplied by Vantiq. The positioning is getting more value from an existing Oracle Health investment at a fraction of the cost, and the route in is a demo request.

What a buyer cannot establish before contact is the unit of charge, which could be per bed, per facility, per clinician user, per module or a platform fee; whether the agentic layer, which rests on a partner's platform, is priced separately; implementation fees, which for configuration inside a hospital's record are usually substantial; and the term.

Ask for the unit of charge, the price of the agentic layer against the workspaces, implementation fees and the term.